“If opportunity doesn’t knock, build a door.” – Milton Berle

@rahulkanadia.bsky.social ky.social, @marubin1.bsky.social and I have launched Verintas Therapeutics Inc.
to target the minor spliceosome in cancer.
Thanks to Nextwave X Partners-our 1st investor and believer.
#Verintas #minorspliceosome

In cancer research, we chase the “untreatable” — but making current treatments more tolerable matters too. Grateful to the SwissLife Jubiläumsstiftung for supporting my work on minor spliceosome-based co-treatments to ease side effects and improve outcomes.
#swisslife #minorspliceosome #RNAbaseddrug